All In Biotech

Free tool

FAERS Monitor: Sabril

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020427 or its brand name (Sabril, Vigabatrin). Reports on generic versions are filed under their own applications.

Reports

13,897

Serious

9,744

70% of reports

Hospitalization

4,399

Death reported

1,337

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure2,541
  • drug ineffective1,368
  • drug dose omission990
  • death842
  • pneumonia521
  • somnolence508
  • drug withdrawal convulsions482
  • off label use443
  • vomiting414
  • hospitalisation369
  • product dose omission issue366
  • epilepsy302
  • condition aggravated280
  • infantile spasms272
  • convulsion267

Reports by year received

View as table
YearReports
200419
200523
200628
200718
200865
200939
2010275
2011219
2012280
2013211
20141,266
20151,569
20161,483
20171,220
2018959
2019785
2020736
2021786
2022887
20231,001
2024910
2025672
2026446

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,262 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infantile spasmsSignal272913.1786.3154,025
drug withdrawal convulsionsSignal482562.2507.1196,513
seizureSignal2,54134.032.880,056
epilepsySignal30215.113.53,926
drug dose omissionSignal9909.18.67,155
convulsionSignal2677.16.31,389
somnolenceSignal5083.83.51,065
hospitalisationSignal3693.63.3708
pneumoniaSignal5212.42.2447
product dose omission issue3661.91.7153
drug ineffective1,3681.61.5302
death8421.51.4136
condition aggravated2801.41.231
vomiting4141.31.235
off label use4430.80.733

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.